• STJ71287 (1µg/ml) staining of Human Liver lysate (35µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.

Anti-Bisphosphate 3 NA-nucleotidase antibody (C-Term) (STJ71287)

SKU:
STJ71287-100

Shipping:
Free Shipping
Current Stock:
Host: Goat
Applications: Pep-ELISA/WB
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Goat polyclonal antibody anti-Bisphosphate 3 nucleotidase (C-Term) is suitable for use in ELISA and Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA
Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Concentration: 0.5 mg/mL
Dilution Range: ELISA-antibody detection limit dilution 1:4000.
Storage Instruction: Store at-20°C on receipt and minimise freeze-thaw cycles.
Gene Symbol: BPNT1
Gene ID: 10380
Uniprot ID: BPNT1_HUMAN
Immunogen Region: C-Term
Accession Number: NP_006076.4
Immunogen Sequence: RNYDYYASRVPESIK
Function Converts adenosine 3'-phosphate 5'-phosphosulfate (PAPS) to adenosine 5'-phosphosulfate (APS) and 3'(2')-phosphoadenosine 5'- phosphate (PAP) to AMP. Has 1000-fold lower activity towards inositol 1,4-bisphosphate (Ins(1,4)P2) and inositol 1,3,4-trisphosphate (Ins(1,3,4)P3), but does not hydrolyze Ins(1)P, Ins(3,4)P2, Ins(1,3,4,5)P4 or InsP6.
Protein Name 3'(2' -5'-Bisphosphate Nucleotidase 1
Bisphosphate 3'-Nucleotidase 1
Pap-Inositol 1 -4-Phosphatase
Pip
Database Links Reactome: R-HSA-156584
Alternative Antibody Names Anti-3'(2' -5'-Bisphosphate Nucleotidase 1 antibody
Anti-Bisphosphate 3'-Nucleotidase 1 antibody
Anti-Pap-Inositol 1 -4-Phosphatase antibody
Anti-Pip antibody
Anti-BPNT1 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance